1. Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis. 2010;32(1–2):35–48.
2. Iranshahi N, Zafari P, Yari K, Alizadeh E. The most common genes involved in epigenetics modifications among Iranian patients with breast cancer: a systematic review. Cell Mol Biol (Noisy-le-grand). 2016;62(12):116–22.
3. Siegel RL, Miller KD, Jemal A. Cancer statistics 2016. CA: Cancer J Clinicians. 2016;66(1):7–30.
4. Yao H, Ashihara E, Maekawa T. Targeting the Wnt/β-catenin signaling pathway in human cancers. Expert Opin Ther Targets. 2011;15(7):873–87.
5. Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan YC, et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene. 2011;30(43):4437–46.